| Name | Title | Contact Details |
|---|
Psymed Inc is a Valley Forge, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Porex Corporation is a Fairburn, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Premium Level: Premium Lifestyle Founded in 2012 by Jason Camper and Paul Gravette, Le-Vel formulates and sells nutritional/health and wellness products like the Le-Vel Thrive product line. Le-Vel is the only health and wellness company that uses cloud-based technology for its day-to-day business operations. Le-Vel`s cloud-based infrastructure enables the company to keep overhead to a minimum while increasing commissions and opportunities for its independent Brand Promoters and putting more money into the Le-Vel THRIVE product line. Some of the products in the Le-Vel line include: Thrive Premium Lifestyle DFT (Derma Fusion Technology), Thrive Premium Lifestyle Capsules, Thrive Premium Lifestyle Mix, Activate, Boost, Balance, Black Label, Café, DFT Duo, Expand, FORM, Thrive Kids, Move, Thrive PRO, Rest, Pure, BURN, THRIVEFIT and Thrive Bites. Le-Vel and the Le-Vel Thrive brand have more than 10 million customers and brand promoters. The company ships within the United States, Canada, Australia, New Zealand, the United Kingdom, and Mexico. In less than 7 years in business, Le-Vel reached $2 billion in lifetime sales.
Shaklee Corporation is a privately held manufacturer and distributor of nutritional supplements, weight-management products, beauty products, and household products.
AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines. We believe the best way we can help patients is to focus on breakthrough science in order to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines. We invest in distinctive science in three main therapy areas where we believe we can make the most meaningful difference to patients: oncology; cardiovascular and metabolic diseases; and respiratory, inflammation and autoimmunity. Our science exploits our rare combination of capabilities in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by a strong focus on translational science and personalised healthcare capabilities. We build on our own capabilities by collaborating with world-renowned scientists and academic institutions and partnering with like-minded science-led companies. Through leading in science, we are confident that we can transform the lives of people around the world and deliver value to our shareholders.